Delivery Order SPE2DB20D1109-SPE2DB25FP62N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,626.77 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion by July 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical...
- AmerisourceBergen Drug Corp was awarded a $26,476.38 firm fixed price delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for ENBREL 50 MG/ML SureClick auto-injector pharmaceutical supply. The contract carries an ultimate completion date of July 25, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $24,386.37 delivery order for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $9,253.56 for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed price, competitively awarded contract carries an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under a larger indefinite delivery contract vehicle and reflects the DLA's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors, with a contract ceiling value of $47,910.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $34,601.94 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injector pharmaceutical product. The delivery order, which carries an ultimate completion date of August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $27,604.58 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $77,016.20 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $10,418.36 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at approximately $15,000 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP62NDelivery Order
AmerisourceBergen Drug Corp was awarded a $4,626.77 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 22, 2025. Performance will be executed from the company's Conshohocken, Pennsylvania location, which serves as its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive experience delivering both brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. The SPE2DX global pharmaceutical support vehicle enables AmerisourceBergen to fulfill federal medical supply needs with flexibility and scalability, supporting the DLA's broader mission to sustain military medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/21/25 |